- Clinical Associate Professor, Global Health
Select from the following:
Andreas Jahn is a clinical epidemiologist with over 16 years of working experience in Africa, primarily in HIV. He has worked the in the academic and program sector. Dr Jahn has published over 80 papers in peer-reviewed journals, including the first evidence globally for a population-level impact of ART roll-out on adult mortality (The Lancet, 2008). He has profoundly contributed to the National ART/PMTCT Program in Malawi which is widely recognized for the best M&E system in resource-limited settings. He continues to shape national and international HIV programs and policy with innovative monitoring systems and initiatives such as Option B+ for PMTCT, which has been adopted as a global recommendation by WHO in 2013.
- PhD (London School of Hygiene & Tropical Medicine (UK))
- MSc (London School of Hygiene & Tropical Medicine (UK))
- MBBS (Freie University of Berlin (Germany))
- Disease Surveillance
- Education and Training
- Health Information Systems
- Health Interventions
- Health Outcomes
- Health Policy
- Health Policy and Advocacy
- Implementation Science
- Intervention Design and Management
- Metrics and Evaluation
- Operations Research
- Policy Monitoring
- Quality Improvement
HIV/AIDS, operations research, task shifting
Prevention of mother-to-child transmission of HIV: a cross-sectional study in Malawi. van Lettow M, Landes M, van Oosterhout JJ, Schouten E, Phiri H, Nkhoma E, Kalua T, Gupta S, Wadonda N, Jahn A, Tippett-Barr B. Bull World Health Organ. 2018 Apr 1;96(4):256-265. doi: 10.2471/BLT.17.203265. Epub 2018 Feb 28.
HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme. Haas AD, van Oosterhout JJ, Tenthani L, Jahn A, Zwahlen M, Msukwa MT, Davies MA, Tal K, Phiri N, Spoerri A, Chimbwandira F, Egger M, Keiser O. J Int AIDS Soc. 2017 Sep 4;20(1):21947. doi: 10.7448/IAS.20.1.21947.
Multi-month prescriptions, fast-track refills, and community ART groups: results from a process evaluation in Malawi on using differentiated models of care to achieve national HIV treatment goals. Prust ML, Banda CK, Nyirenda R, Chimbwandira F, Kalua T, Jahn A, Eliya M, Callahan K, Ehrenkranz P, Prescott MR, McCarthy EA, Tagar E, Gunda A. J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21650. doi: 10.7448/IAS.20.5.21650.
Lessons Learned From Option B+ in the Evolution Toward "Test and Start" From Malawi, Cameroon, and the United Republic of Tanzania. Kalua T, Tippett Barr BA, van Oosterhout JJ, Mbori-Ngacha D, Schouten EJ, Gupta S, Sande A, Zomba G, Tweya H, Lungu E, Kajoka D, Tih P, Jahn A. J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S43-S50. doi: 10.1097/QAI.0000000000001326. Review.
Scaling-up antiretroviral therapy in Malawi. Jahn A, Harries AD, Schouten EJ, Libamba E, Ford N, Maher D, Chimbwandira F. Bull World Health Organ. 2016 Oct 1;94(10):772-776. Epub 2016 Jul 27.